[{"NetIncomeLoss_1_Q2_USD":-16462000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":10395732.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":10276180.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.9,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.9,"DerivativeLiabilitiesCurrent_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.005,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-12000.0,"Depreciation_2_Q2_USD":28000000.0,"Depreciation_1_Q2_USD":15000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":168000.0,"AssetsCurrent_0_Q2_USD":124625000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-74000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":13455145000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":210000.0,"IncomeTaxesPaidNet_2_Q2_USD":14000.0,"CommonStockSharesIssued_0_Q2_shares":10395732.0,"Assets_0_Q2_USD":125893000.0,"ShareBasedCompensation_2_Q2_USD":4535000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":504000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":16386314.0,"DeferredRevenue_0_Q2_USD":300000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6260000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"GeneralAndAdministrativeExpense_2_Q2_USD":10804000.0,"OperatingLeaseLiability_0_Q2_USD":446000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":21780000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10189000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":481000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-58000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-24000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":517000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":67000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-11000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":300000.0,"CommonStockValue_0_Q2_USD":10000.0,"OtherReceivablesNetCurrent_0_Q2_USD":228000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":113000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":16240000.0,"OtherAssetsCurrent_0_Q2_USD":511000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":6698000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":2442000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":976000.0,"OtherAssetsNoncurrent_0_Q2_USD":667000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":123233000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":261000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":930702000.0,"Cash_0_Q2_USD":2256000.0,"Liabilities_0_Q2_USD":9242000.0,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":120977000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":103000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":35000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-48307000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16473000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3617000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24225000.0,"LiabilitiesCurrent_0_Q2_USD":8981000.0,"AccountsPayableCurrent_0_Q2_USD":1983000.0,"NonoperatingIncomeExpense_1_Q2_USD":-24000.0,"NonoperatingIncomeExpense_2_Q2_USD":-15723000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":123533000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1392000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.88,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.88,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":67000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.065,"ShortTermLeaseCost_2_Q2_USD":29000.0,"ShortTermLeaseCost_1_Q2_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.004,"OperatingLeasePayments_2_Q2_USD":104000.0,"OperatingLeasePayments_1_Q2_USD":52000.0,"PrepaidInsurance_0_Q2_USD":233000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":97000.0,"NetIncomeLoss_2_Q2_USD":-48374000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":471000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-972000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":10395732.0,"OperatingIncomeLoss_2_Q2_USD":-32584000.0,"OperatingIncomeLoss_1_Q2_USD":-16449000.0,"PreferredStockValue_0_Q2_USD":null,"OperatingLeaseCost_1_Q2_USD":50000.0,"OperatingLeaseCost_2_Q2_USD":101000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":125893000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4535000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3617000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":568000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":185000.0,"OperatingExpenses_1_Q2_USD":16449000.0,"OperatingExpenses_2_Q2_USD":32584000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-546000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.58,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-4.71,"ProfitLoss_2_Q2_USD":-48374000.0,"StockholdersEquity_0_Q2_USD":116651000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":12000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":300000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-814061000.0,"LeaseCost_1_Q2_USD":57000.0,"LeaseCost_2_Q2_USD":130000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-24295000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":854000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]